Introduction
NAD+ telehealth commonly involves intake, a clinician review, pharmacy fulfillment if prescribed, and recurring billing. The useful expectation is a transparent process: the service should identify the route and formulation, explain which pharmacy dispenses it, state what the price includes, and leave eligibility to the clinician.
Current human evidence does not establish a general wellness result from the offered product.
What a transparent NAD+ telehealth process looks like
A telehealth brand, clinical entity, and dispensing pharmacy may be separate organizations. Ask which role each plays before paying.
The intake is a clinical review step, not an approval signal. A clinician may request more information, decline to prescribe, or discuss another approach.
A transparent NAD+ telehealth process has several distinct roles: the consumer supplies history, a clinician reviews it, a pharmacy dispenses if a prescription is issued, and the telehealth brand manages the service experience. Those roles can be held by different organizations. A clear page should say who does what before asking a reader to pay.
Compare published NAD+ telehealth terms by route
These rows come from Telehealth Ledger's canonical catalog. A low headline price only ranks when medication is included and the continuing or prepaid basis is comparable.
Live Vital
NAD+ · Provider-guided · medication included
Price source · checked 2 August 2026CoreAge Rx
NAD+ injectable · Subcutaneous injection · medication included
Price source · checked 18 August 2026Bodybuilding Health+
NAD+ injection · Subcutaneous injection · medication included
Price source · checked 22 August 2026Strut Health
NAD+ injection · Subcutaneous injection · medication included
Price source · checked 30 August 2026System Labs
NAD+ Injection · Injection · medication included
Price source · checked 28 August 2026Showing the 5 lowest comparable published prices from 10 eligible providers. The complete comparison includes every current catalog row.
- Hone Health: Estimated $165/mo plus membershipMedication or membership billed separately
Telos RX
NAD+ nasal · Nasal · medication included
Price source · checked 22 August 2026System Labs
NAD+ Nasal Spray · Nasal spray · medication included
Price source · checked 28 August 2026Pallas Health
NAD+ nasal spray · Intranasal spray · medication included
Price source · checked 22 August 2026MadeMed
NAD+ Nasal Spray · Nasal spray · medication included
Price source · checked 2 August 2026- Bodybuilding Health+: From $129 / one monthMedication included as published
Eligibility, prescribed quantity, state availability, pharmacy fulfillment, shipping, supplies, and follow-up can change the final cost. Unknown fields remain unknown.
What to verify before enrolling
Verify the exact route, formulation, dispensing pharmacy, state availability, medication inclusion, refill interval, shipping, cancellation terms, and membership or prepaid commitment. These are published commercial facts that can change.
Keep the process question separate from the evidence question. A smooth intake and a low price do not establish product quality or a clinical outcome.
The first decision is the proposed route and formulation. Injection, nasal, and oral NAD-related offers are not interchangeable, and the available human evidence is heavily route dependent. Ask for the exact product name, whether it is compounded, the dispensing pharmacy, and the evidence that matches the actual route rather than accepting a broad NAD+ wellness description.
What is comparable and what is not
The key consumer comparison is not 'which program promises the most?' It is which program publishes a current price basis, what it includes, who is involved, and which facts remain unverified.
The quoted price is useful only when its denominator is visible. Readers should be able to tell whether it covers medication if prescribed, clinical intake, follow-up, shipping, supplies, refills, an introductory period, or a membership commitment. A dated program card with unknown fields is more actionable than a polished price claim that hides those distinctions.
| Source type | Can support | Cannot support |
|---|---|---|
| FDA label or communication | Regulatory and safety facts in that document | A personalized treatment plan |
| Human trial or study | Its population, route, and measured outcomes | A promised individual result |
| Current program catalog | Published price and terms | Clinical effectiveness or eligibility |
Safety and escalation
Symptoms such as shaking or chills, chest pressure, rapid heart rate, severe vomiting, low-blood-pressure symptoms, or allergic reaction after an injectable product need clinical assessment. Chest pain, trouble breathing, fainting, confusion, or severe allergic symptoms need urgent evaluation.
Intake completion is not a clinical result or a prescription approval. A clinician may ask for more information, determine that a product is not appropriate, or discuss an alternative. That is a normal care process, not a failure of the program. The article should say this once, plainly, then return to the evidence and operational questions the reader can actually use.
Do not use this article for dosing, vial math, injection instructions, or a decision to start, stop, or switch a prescription.
How to read a telehealth offer
Read the price module as a commercial comparison. It should separate injection, nasal, and oral routes, label medication inclusion and refill cadence, and never imply a clinical ranking.
After an injectable product, significant new symptoms deserve contact with the treating team. Chest pain, trouble breathing, fainting, confusion, or severe allergic symptoms need urgent evaluation. The program's logistics, pricing, and messaging are separate from that safety pathway, which should be easy to find rather than buried in a footer.
- Confirm the product or formulation actually being offered.
- Check whether medication, visits, membership, supplies, and shipping are included.
- Ask which pharmacy will dispense the prescription and what remains unknown.
- Confirm current state availability and cancellation terms directly.
What should trigger a refresh
Refresh when provider price, pharmacy, state, cancellation, availability, or FDA safety facts change. A current source date is part of the answer.
Before enrolling, readers should leave with a short written record of what the provider actually publishes: the route and formulation, whether medication is included if prescribed, the recurring rather than introductory price, refill timing, the clinical entity, dispensing pharmacy if named, state availability, shipping, and cancellation. These are not minor details. They determine whether two telehealth offers are comparable at all. The evidence question comes alongside them: what direct human study supports the precise product and outcome being marketed? If the program cannot identify either its operating terms or its evidence basis, the honest comparison should preserve that gap instead of filling it with generic NAD+ biology.
Common questions
- Will a telehealth intake guarantee a NAD+ prescription?
- No. Eligibility and prescribing are clinician decisions.
- Does the telehealth brand always dispense the product?
- Not necessarily. Ask which pharmacy would fill the specific prescription.
- Does a lower monthly price mean a lower total?
- Not necessarily. Check medication inclusion, care fees, refill interval, and shipping.
- What should I do with a serious reaction?
- Seek clinical or urgent evaluation for serious symptoms rather than relying on this article.
Expect transparency, not a forecast
The best NAD+ telehealth program comparison exposes price basis, pharmacy and formulation evidence, state and cancellation facts, and clinical limits. It does not promise eligibility or an outcome.
Sources
- Compounding and the FDA: questions and answersU.S. Food and Drug Administration · Accessed 28 August 2026
FDA's statement that compounded drugs are not FDA-approved and are not premarket reviewed for safety, effectiveness, or quality.
- FDA reminder on ingredients suitable for sterile compoundingU.S. Food and Drug Administration · Accessed 28 August 2026
FDA's NAD+ sterile-compounding ingredient-quality warning and reported adverse-event context.
- Human plasma and urine NAD+ metabolome during a six-hour IV infusionPubMed · Accessed 28 August 2026
Small direct-IV NAD+ human metabolome pilot and its narrow scope.
- IV NAD+ versus IV nicotinamide riboside tolerability pilotPubMed · Accessed 28 August 2026
Retrospective commercial IV tolerability observations, including limits of the design and follow-up.
- NAD+ in ischemic-cardiomyopathy heart failurePubMed · Accessed 28 August 2026
Disease-specific randomized IV NAD+ trial context, not wellness-injection evidence.
- High-dose nicotinamide riboside safety trialPubMed · Accessed 28 August 2026
Oral nicotinamide-riboside evidence that must remain separate from injectable NAD+ claims.
Refresh triggers
- Provider price, pharmacy, state, or cancellation update
- FDA NAD+ safety/compounding communication
- New direct human NAD+ evidence